Stingray Therapeutics

company

About

Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.

  • 1 - 10

Details

Last Funding Type
Non-Equity Assistant
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.

The company was founded in 2018 and is based in Houston, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Stingray Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Oct 1, 2020 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2020 Non-Equity Assistant 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Stingray Therapeutics is funded by 1 investors. Newchip are the most recent investors.
Investor Name Lead Investor Funding Round
Newchip Non-Equity Assistant